MedTrace Logo

Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device

NCT07126938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-08-26

No results posted yet for this study

Summary

This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol consuming) group, underwent baseline and post-consumption ocular assessments using the device. These assessments included: Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. The Gaize headset measured gaze vector and pupil size at 90 hertz per eye.

Conditions

  • Alcohol Impairment
  • Nystagmus
  • Virtual Reality
  • Lack of Smooth Pursuit
  • Impairment
  • Alcohol Intoxication
  • Intoxication

Interventions

DRUG

Alcoholic beverage

Participants in the experimental group consumed self-selected amounts of alcohol, monitored by study staff to ensure safety and compliance with protocol guidelines. Participants then filled out the remainder of the general health questionnaire, including how many drinks they consumed, and whether or not they feel too impaired to drive a vehicle or go to work.

Sponsors & Collaborators

  • Gaize

    lead INDUSTRY

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-21
Primary Completion
2024-11-22
Completion
2024-11-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07126938 on ClinicalTrials.gov